As noted by other groups [64, 65], we have identified Mitoxantrone, a drug that was used to treat acute myeloid leukaemia and multiple sclerosis, as a potential hit against Nsp3 in our virtual screening experiments. Here, SH2D3C is linked to multiple sclerosis.